Exfoliation of expanded GO represents an attractive route to functionalized graphenes as versatile 2D carbon nanomaterials and components of a wide variety of polymer nanocomposites. Thermally reduced graphite oxides (TrGO) with specific surface areas of 600 to 950 m2 · g−1 were obtained by oxidation of graphite followed by thermal expansion at 600 °C. Thermal post treatment at 700 °C and 1 000 °C increased carbon content (81 to 97 wt.‐%) and lowered resistivity (1 600 to 50 Ω · cm). During melt extrusion with PC, iPP, SAN and PA6, exfoliation afforded uniformly dispersed graphenes with aspect ratio > 200. In comparison to conventional 0D and 1D carbon nanoparticles, TrGO afforded nanocomposites with improved stiffness and lower percolation threshold. Recent progress and new strategies in development of functionalized graphenes and graphene‐based nanocomposites are highlighted.magnified image
Graphene nanocomposites are prepared by chemical reduction of graphite oxide (GO) dispersion with vitamin C in the presence of SAN latex followed by melt compounding. In this process, GO is well dispersed in an aqueous SAN emulsion before reduction. During reduction the SAN latex is adsorbed on the graphene sheets of the chemically reduced GO (CRGO). After melt compounding of such hybrid particles with SAN, the nanocomposites show uniform dispersion of CRGO in SAN resulting in improved stiffness with respect to SAN/graphite. The reduction of GO in the presence of polymer latex represents a versatile route to graphene masterbatches and does not require either drying of GO or thermal GO expansion at high temperatures. magnified image
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.